About the Authors

Anne-Sophie Hamy

Contributed equally to this work with: Anne-Sophie Hamy, Hélène Bonsang-Kitzis

Affiliation Institut Curie, PSL Research University, Translational Research Department, INSERM, U932 Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2Lab), Paris, France

Hélène Bonsang-Kitzis

Contributed equally to this work with: Anne-Sophie Hamy, Hélène Bonsang-Kitzis

Affiliations Institut Curie, PSL Research University, Translational Research Department, INSERM, U932 Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2Lab), Paris, France, Department of Surgery, Institut Curie, Paris, France

Marick Lae

Affiliation Department of Tumor Biology, Institut Curie, Paris, France

Matahi Moarii

Affiliations Mines Paristech, PSL-Research University, CBIO-Centre for Computational Biology, Mines ParisTech, Fontainebleau, France, U900, INSERM, Institut Curie, Paris, France

Benjamin Sadacca

Affiliations Institut Curie, PSL Research University, Translational Research Department, INSERM, U932 Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2Lab), Paris, France, Laboratoire de Mathématiques et Modélisation d’Evry, Université d’Évry Val d’Essonne, Evry, France

Alice Pinheiro

Affiliation Institut Curie, PSL Research University, Translational Research Department, INSERM, U932 Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2Lab), Paris, France

Marion Galliot

Affiliation Institut Curie, PSL Research University, Translational Research Department, INSERM, U932 Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2Lab), Paris, France

Judith Abecassis

Affiliations Institut Curie, PSL Research University, Translational Research Department, INSERM, U932 Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2Lab), Paris, France, Mines Paristech, PSL-Research University, CBIO-Centre for Computational Biology, Mines ParisTech, Fontainebleau, France, U900, INSERM, Institut Curie, Paris, France

Cecile Laurent

Affiliation Institut Curie, PSL Research University, Translational Research Department, INSERM, U932 Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2Lab), Paris, France

Fabien Reyal

fabien.reyal@curie.fr

Affiliations Institut Curie, PSL Research University, Translational Research Department, INSERM, U932 Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2Lab), Paris, France, Department of Surgery, Institut Curie, Paris, France

Competing Interests

The authors have declared that no competing interests exist.

Author Contributions

Conceptualization: FR AP MG. Data curation: BS. Formal analysis: BS JA. Investigation: BS CL. Methodology: CL MM. Project administration: FR CL. Resources: ML. Supervision: FR. Validation: ML. Writing – original draft: ASH HBK. Writing – review & editing: ASH.